Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Payments for (Proceeds from) Other Investing Activities

1.4 / 5 stars · 24/87 Roast Me

Elanco Animal Health Incorporated Payments for (Proceeds from) Other Investing Activities

Elanco Animal Health Incorporated (ELAN) reported Payments for (Proceeds from) Other Investing Activities of $10.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-05

  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $1.00M.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $9.00M, a 350.00% increase year-over-year.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $2.00M, a 0.00% change year-over-year.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was $9.00M, a 12.50% increase year-over-year.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for fiscal 2025 was $12.00M, a 14.29% decline from fiscal 2024.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for fiscal 2024 was $14.00M, a 40.00% increase from fiscal 2023.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for fiscal 2023 was $10.00M, a 25.00% increase from fiscal 2022.
  • Elanco Animal Health Incorporated payments for (proceeds from) other investing activities for fiscal 2022 was $8.00M.
Period endPayments for (Proceeds from) Other Investing Activities 3 monthPayments for (Proceeds from) Other Investing Activities 3 month as first filedPayments for (Proceeds from) Other Investing Activities 6 monthPayments for (Proceeds from) Other Investing Activities 6 month as first filedPayments for (Proceeds from) Other Investing Activities 9 monthPayments for (Proceeds from) Other Investing Activities 9 month as first filedPayments for (Proceeds from) Other Investing Activities 12 monthPayments for (Proceeds from) Other Investing Activities 12 month as first filed
2026-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$10.00M
10-Q · filed 2026-08-05
$12.00M
derived: sum of 3 quarters · filed 2026-08-05
$21.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$9.00M
10-Q · filed 2026-05-06
$11.00M
derived: sum of 2 quarters · filed 2026-05-06
$20.00M
derived: sum of 3 quarters · filed 2026-05-06
$19.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$11.00M
derived: sum of 2 quarters · filed 2026-02-24
$10.00M
derived: sum of 3 quarters · filed 2026-08-05
$12.00M
10-K · filed 2026-02-24
2025-09-30$9.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$8.00M
derived: sum of 2 quarters · filed 2026-08-05
$10.00M
10-Q · filed 2025-11-05
$12.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.00M
10-Q · filed 2026-08-05
$3.00M
derived: sum of 3 quarters · filed 2026-08-05
$11.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$2.00M
10-Q · filed 2026-05-06
$4.00M
derived: sum of 2 quarters · filed 2026-05-06
$12.00M
derived: sum of 3 quarters · filed 2026-05-06
$11.00M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$10.00M
derived: sum of 2 quarters · filed 2026-02-24
$9.00M
derived: sum of 3 quarters · filed 2026-02-24
$14.00M
10-K · filed 2026-02-24
$0.00
10-K · filed 2025-02-25
2024-09-30$8.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$7.00M
derived: sum of 2 quarters · filed 2025-11-05
$12.00M
10-Q · filed 2025-11-05
-$1.00M
10-Q · filed 2024-11-07
$20.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$4.00M
10-Q · filed 2025-08-07
-$1.00M
10-Q · filed 2024-08-08
$12.00M
derived: sum of 3 quarters · filed 2026-02-24
$12.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$5.00M
10-Q · filed 2025-05-07
$0.00
10-Q · filed 2024-05-08
$13.00M
derived: sum of 2 quarters · filed 2026-02-24
$13.00M
derived: sum of 3 quarters · filed 2026-02-24
$14.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$8.00M
derived: sum of 2 quarters · filed 2026-02-24
$9.00M
derived: sum of 3 quarters · filed 2026-02-24
$10.00M
10-K · filed 2026-02-24
-$4.00M
10-K · filed 2024-02-26
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.00M
derived: sum of 2 quarters · filed 2024-11-07
$2.00M
10-Q · filed 2024-11-07
$12.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$2.00M
10-Q · filed 2024-08-08
$12.00M
derived: sum of 3 quarters · filed 2025-02-25
$3.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$1.00M
10-Q · filed 2024-05-08
$11.00M
derived: sum of 2 quarters · filed 2025-02-25
$2.00M
derived: sum of 3 quarters · filed 2025-02-25
$6.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$1.00M
derived: sum of 2 quarters · filed 2025-02-25
$5.00M
derived: sum of 3 quarters · filed 2025-02-25
$8.00M
10-K · filed 2025-02-25
2022-09-30-$9.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$5.00M
derived: sum of 2 quarters · filed 2023-11-07
-$2.00M
10-Q · filed 2023-11-07
$9.00M
10-Q · filed 2022-11-08
-$19.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$7.00M
10-Q · filed 2023-08-07
-$10.00M
derived: sum of 3 quarters · filed 2024-02-26
-$9.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$3.00M
10-Q · filed 2023-05-09
-$14.00M
derived: sum of 2 quarters · filed 2024-02-26
-$13.00M
derived: sum of 3 quarters · filed 2024-02-26
-$13.00M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31-$17.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$16.00M
derived: sum of 2 quarters · filed 2024-02-26
-$16.00M
derived: sum of 3 quarters · filed 2024-02-26
-$9.00M
10-K · filed 2024-02-26
$8.00M
10-K · filed 2022-02-28
2021-09-30$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$1.00M
derived: sum of 2 quarters · filed 2022-11-08
$8.00M
10-Q · filed 2022-11-08
-$26.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$7.00M
10-Q · filed 2022-08-08
-$27.00M
derived: sum of 3 quarters · filed 2023-03-01
-$20.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$7.00M
10-Q · filed 2022-05-09
-$27.00M
derived: sum of 2 quarters · filed 2023-03-01
-$20.00M
derived: sum of 3 quarters · filed 2023-03-01
-$19.00M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$27.00M
derived: sum of 2 quarters · filed 2023-03-01
-$26.00M
derived: sum of 3 quarters · filed 2023-03-01
-$26.00M
10-K · filed 2023-03-01
$7.10M
10-K · filed 2021-03-01
2020-09-30$7.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$8.00M
derived: sum of 2 quarters · filed 2021-11-05
$8.00M
10-Q · filed 2021-11-05
-$28.70M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$1.00M
10-Q · filed 2021-08-09
$1.30M
10-Q · filed 2020-07-30
-$35.70M
derived: sum of 3 quarters · filed 2022-02-28
$3.20M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$0.00
10-Q · filed 2021-05-07
$400.00K
10-Q · filed 2020-05-07
-$36.70M
derived: sum of 2 quarters · filed 2022-02-28
$2.20M
derived: sum of 3 quarters · filed 2022-02-28
$4.50M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$36.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$2.20M
derived: sum of 2 quarters · filed 2022-02-28
$4.50M
derived: sum of 3 quarters · filed 2022-02-28
$5.00M
10-K · filed 2022-02-28
$4.90M
10-K · filed 2020-02-28
2019-09-30$38.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$41.20M
derived: sum of 2 quarters · filed 2020-11-06
$41.70M
10-Q · filed 2020-11-06
$37.00M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$2.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$2.80M
10-Q · filed 2020-07-30
$25.70M
10-Q · filed 2019-08-13
-$1.90M
derived: sum of 3 quarters · filed 2021-03-01
$1.70M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$500.00K
10-Q · filed 2020-05-07
-$4.20M
derived: sum of 2 quarters · filed 2021-03-01
-$600.00K
derived: sum of 3 quarters · filed 2021-03-01
-$1.30M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$1.10M
derived: sum of 2 quarters · filed 2021-03-01
-$1.80M
derived: sum of 3 quarters · filed 2021-03-01
-$100.00K
10-K · filed 2021-03-01
$1.90M
10-K · filed 2019-02-20
2018-09-30$3.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$2.90M
derived: sum of 2 quarters · filed 2019-11-08
$4.60M
10-Q · filed 2019-11-08
-$7.70M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$700.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$1.00M
10-Q · filed 2019-08-13
-$11.30M
derived: sum of 3 quarters · filed 2020-02-28
2018-03-31$1.70M
10-Q · filed 2019-05-14
-$10.60M
derived: sum of 2 quarters · filed 2020-02-28
2017-12-31-$12.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$3.00M
10-K · filed 2020-02-28
$21.50M
10-K · filed 2019-02-20
2017-09-30$15.30M
10-Q · filed 2018-11-08
2016-12-31$34.20M
10-K · filed 2019-02-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05